What are Viral Vectors and Plasmid DNA used for?

Viral vectors and plasmid DNA are utilized in gene therapy, gene editing, and vaccine development to deliver genetic material into cells for therapeutic or research purposes.

How big is the Viral Vectors and Plasmid DNA Manufacturing Market?

The global Viral Vectors and Plasmid DNA Manufacturing Market size was estimated at USD 5.3 Billion in 2023 and is expected to reach USD 36.5 Billion in 2033.

Who are the key companies/players in the Viral Vectors and Plasmid DNA Manufacturing Market?

Some of the key players in the Viral Vectors and Plasmid DNA Manufacturing Markets are Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Cobra Biologics, Catalent Inc., Wuxi Biologics, Takara Bio Inc., Waisman Biomanufacturing, Genezen laboratories, Batavia Biosciences, Miltenyi Biotec GmbH.

How do Viral Vectors and Plasmid DNA contribute to medical advancements?

These manufacturing technologies enable the development of innovative treatments for various diseases, including genetic disorders, cancers, and infectious diseases, leading to improved patient outcomes.

What factors are driving the growth of the Viral Vectors and Plasmid DNA Manufacturing Market?

The increasing demand for gene therapy, advancements in gene editing technologies, rising research activities, investments in the pharmaceutical and biotechnology industries, favorable regulatory conditions, and integration of advanced computing technologies are driving market growth.

How do Viral Vectors and Plasmid DNA manufacturing technologies impact healthcare?

These technologies enable the development of targeted therapies, personalized medicines, and novel vaccines, revolutionizing the treatment landscape and offering new hope for patients with challenging medical conditions.

Global Viral Vectors and Plasmid DNA Manufacturing Market By Vector Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Other Vector Types) By Workflow Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting) Downstream Manufacturing(Purification, Fill Finish) By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Other Applications) By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes, Disease, Cancer, and Others) and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: July 2024
Report ID: 13644
Number of Pages: 312
Format:

- Merck KGaA Company Profile
- Lonza Group AG Company Profile
- FUJIFILM Diosynth Biotechnologies
- Thermo Fisher Scientific Company Profile
- Cobra Biologics
- Catalent Inc.
- Wuxi Biologics
- Takara Bio Inc.
- Waisman Biomanufacturing
- Genezen laboratories
- Batavia Biosciences
- Miltenyi Biotec GmbH
Settings

Related Reports

Our Clients

Inquiry Before Buying

Viral Vectors and Plasmid DNA Manufacturing Market

Report ID 13644
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (53)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)